Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study
NCT ID: NCT06672913
Last Updated: 2024-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2024-09-01
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Primary Objective: To evaluate the rate of receiving exclusive mothers' milk at discharge for infants born ≤ 32 weeks of gestation who have received skin-to-skin care in accordance with the study protocol.
2. Secondary Objective: To evaluate the rates of neonatal sepsis, intraventricular hemorrhage, and necrotizing enterocolitis (stage 2 and above) as well as the length of hospital stay for infants born at or below 32 weeks of gestation who have received skin-to-skin care in accordance with the study protocol.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Mother-infant Skin-to-skin Contact on Stress Response of Preterm Infants
NCT05503238
Continuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm Infants
NCT05975203
The Effect of Skin Care Applied With Two Different Oils on Skin Integrity and Growth Parameters in Premature Babies
NCT04972747
Skin-to-skin Contact During the Transfer From the Delivery Room to the Neonatal Intensive Care Unit: Impact on Very Preterm Infants and Their Parents
NCT05820386
Effect of a Bathing Care Package on Comfort and Skin Moisture in Preterm Infants in a Neonatal Intensive Care Unit
NCT07068737
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Skin-to-skin care has been shown to be effective in improving breastfeeding rates, enhancing bonding, better physiological stability, reducing stress levels, shortening hospital stays, decreasing the risk of infections, lowering rates of intraventricular hemorrhage, and improving weight gain and parental confidence. Additionally, it has been shown to be most effective when skin-to-skin care is applied for more than one hour in a single session and for more than eight hours in a day. This can be best assured if a protocol exists in the units.
2. Objective: This study is a multi-center, prospective pre-post clinical study conducted under the leadership of the Turkish Neonatal Society. It aims to investigate the effects of a standardized skin-to-skin care application, which is initiated early and applied regularly, on clinical outcomes for preterm infants born at less than 32 weeks of gestation.
1. Primary Objective: To evaluate the rate of receiving exclusive mothers' milk at discharge for infants born ≤ 32 weeks of gestation who have received skin-to-skin care in accordance with the study protocol.
2. Secondary Objective: To evaluate the rates of neonatal sepsis, intraventricular hemorrhage, and necrotizing enterocolitis (stage 2 and above) as well as the length of hospital stay for infants born at or below 32 weeks of gestation who have received skin-to-skin care in accordance with the study protocol.
3. Method: Eight training institutions (hospitals) from different geographical regions of Turkiye will be selected. Once the chair of the selected NICUs express their consent to participate, detailed information about the project will be provided to them. The training program developed regarding the skin-to-skin care approach will be delivered in a face-to-face format on a full training day for the responsible physicians and nursing staff working in the units. The theoretical lesson program will consist of three 45-minute lessons (history, standard skin-to-skin care application, skin-to-skin care application for at-risk infants). Practical lessons will be conducted in pairs using a realistic scenario with models. Following the theoretical and practical lessons, the aim is to implement skin-to-skin care based on a standardized protocol for at least one hour per each session, initiated early and regularly.
a. The skin-to-skin care application proposed by the Turkish Neonatology Association is as follows:
i. Duration: At least one hour per session
ii. Time to initiate first skin-to-skin care:
GA: \< 28 weeks: After the 72nd hour GA: 28 - 32 weeks: As soon as stabilization is ensured
iii. Criteria to accepted as stabilization: Absence of hypothermia Normal arterial tension with or without inotropic treatment Vital signs stable or easily normalized after nursing care Absence of frequent (\>3/hour) and profound (any apnea requiring positive pressure ventilation in the last three hours) apnea
b. Data Recording: Feeding details at discharge (Exclusive mothers'milk, ≥ 50% mothers' milk, \< 50% mothers' milk, Formula) and data regarding outcomes (sepsis, intraventricular hemorrhage, necrotizing enterocolitis, duration of hospitalization) will be recorded for patients in the pre-education and post-education groups in each unit. The pre-education group includes infants discharged from the units in the two months prior to training, while the post-education group includes infants discharged from the units between the fourth and sixth months after training. Data collected before and after the intervention will be analyzed.
c. Sample Size: To determine the sample size, a power analysis was conducted using the OpenEpi program. Assuming a 95% confidence level (1-α), an 80% test power (1-β), and an expected effect size of d=0.25, it was determined that at least 59 samples are required in each group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
Intervention: Teoritical and practical education on skin to skin contact to ensure the application of Turkish Neonatal Society skin to skin contact protocol.
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre education
The infants born at less than 32 weeks and discharged from the units in the last two months before training.
No interventions assigned to this group
Post education
The infants born at less than 32 weeks and discharged between four to six months after training
skin to skin contact care
Early and regular skin to skin contact in NICU GA: \< 28 weeks: After the 72nd hour GA: 28 - 32 weeks: As soon as stabilization is ensured
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
skin to skin contact care
Early and regular skin to skin contact in NICU GA: \< 28 weeks: After the 72nd hour GA: 28 - 32 weeks: As soon as stabilization is ensured
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Abdominal wall defects
1 Day
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara University
OTHER
Gazi University
OTHER
Hacettepe University
OTHER
Marmara University
OTHER
Umraniye Education and Research Hospital
OTHER_GOV
Trakya University
OTHER
Ege University
OTHER
Ondokuz Mayıs University
OTHER
Cukurova University
OTHER
Sanliurfa Harran University
UNKNOWN
Cumhuriyet University
OTHER
Uludag University
OTHER
Kocaeli University
OTHER
Aydin Adnan Menderes University
OTHER
Konya City Hospital
OTHER
Baskent University
OTHER
Baskent University Ankara Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sezin Unal
Prof, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Esin Koc, Prof, MD
Role: STUDY_CHAIR
Gazi University
Saadet Arsan, Prof, MD
Role: STUDY_DIRECTOR
Ankara University
Hülya Bilgen, Prof, MD
Role: STUDY_DIRECTOR
Marmara University
İlke Mungan Akın, Prof, MD
Role: STUDY_DIRECTOR
Umraniye Teaching and Research Hospital
Betül Acunaş, Prof, MD
Role: STUDY_DIRECTOR
Trakya University
Mehmet Yalaz, Prof, MD
Role: STUDY_DIRECTOR
Ege University
Sezin Unal, Prof, MD
Role: STUDY_DIRECTOR
Baskent University
Sule Yigit, Prof, MD
Role: STUDY_DIRECTOR
Hacettepe University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baskent University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TR-SSCinNICU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.